Fresenius Group

Fresenius Group is a global healthcare company headquartered in Bad Homburg vor der Höhe, Germany. It provides system-critical products and services for leading therapies used in the care of critically and chronically ill patients, spanning (Bio)Pharma including clinical nutrition, MedTech, and Care Provision. The group reported annual revenue of €21.5 billion in fiscal year 2024 and employs approximately 176,000 people, excluding Fresenius Medical Care, with operations across Europe, the Americas and other global markets.

The group's activities are organised around several operating companies. Fresenius Kabi supplies products for critically and chronically ill patients. Fresenius Helios is Europe's leading private hospital operator. Fresenius Medical Care, held as an investment company, is the world's leading provider of dialysis products and services, serving around 4.5 million patients worldwide. Industry verticals include pharmaceuticals and biopharma, clinical nutrition, medical technology, private hospital operations, and renal and dialysis care.

Under the #FutureFresenius programme, the company is focusing on three therapy platforms: (Bio)Pharma including clinical nutrition, MedTech, and Care Provision. Its stated mission is to save and improve human lives with affordable, accessible and innovative healthcare products and the highest quality in clinical care. The company draws on a heritage of more than 100 years.